BioCentury
ARTICLE | Clinical News

Hepatitis C antigens: Began Phase I study

December 4, 2000 8:00 AM UTC

Enzo Biochem Inc. (ENZ), Farmingdale, N.Y. Product: Hepatitis C antigens Business: Infectious diseases, Cancer Therapeutic category: Immune modulation Target: Immune cells Description: Oral hepatitis ...